Inhibitors of hepatitis C virus
US-10335409-B2 · Jul 2, 2019 · US
Inhibitors of hepatitis C virus
US10603318B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10603318-B2 |
| Application number | US-201916409610-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 10, 2019 |
| Priority date | Jul 3, 2012 |
| Publication date | Mar 31, 2020 |
| Grant date | Mar 31, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of formula: 2. A compound of formula:
Assignees
Inventors
Classifications
the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu · CPC title
- C07K5/0812Primary
and aromatic or cycloaliphatic · CPC title
in which the condensed system contains four or more hetero rings · CPC title
ortho- or peri-condensed with heterocyclic rings · CPC title
not condensed and containing further heterocyclic rings · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10603318B2 cover?
- Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
- Who is the assignee on this patent?
- Gilead Pharmasset Llc
- What technology area does this patent fall under?
- Primary CPC classification C07K5/0812. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).